Ginza 1-Chome Clinic: Hybrid MAT Macrophage Activation Therapy
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
Located in the bustling district of Tokyo, Ginza 1-Chome Clinic is renowned for its "gentle yet highly effective" approach to supportive cancer immunotherapy. The clinic's core technology, Hybrid MAT (Macrophage Activation Therapy), aims to build a solid anti-cancer defense line by activating macrophages—the body's most important "immune scavengers."
Core Technology: Hybrid MAT Dual Activation Protocol
Unlike traditional cell therapies that require massive blood collection and ex vivo culture, Hybrid MAT employs a simpler and safer strategy:
- IAF Plant-Derived IV: A weekly intravenous infusion using high-purity plant components to induce the transformation of internal macrophages into anti-tumor M1 types.
- ARL Oral Activator: Taken daily at home to provide continuous activation signals, ensuring the immune system remains in a high state of alert.
- M1/M2 Balance Regulation: Precisely inhibits M2 macrophages that promote tumor growth while strengthening M1 macrophages that attack tumors, achieving immune remodeling of the microenvironment.
Benefits and Safety
- No Massive Blood Collection: Significantly reduces the physical burden and risk of anemia for patients with advanced cancer.
- Plant-Based Components: High safety profile with very few serious side effects; can be used in conjunction with conventional chemotherapy or radiotherapy.
- Pain Relief Effects: Clinical observations indicate that macrophage activation helps alleviate cancer-related pain and improves the patient's quality of life (QoL).
Medical Consultant's Review
The protocol provided by Ginza 1-Chome Clinic is ideal for patients "seeking low-invasiveness supportive therapy." For those undergoing standard nurturing cares who wish to enhance their immune response, or patients whose physical condition is unsuitable for large-scale cell culture, Hybrid MAT is a high-quality choice that combines evidence-based science with convenience.
【Medical Supporter Guardian Statement】 Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.